Company Overview - Weifang Jitao Medical Technology Co., Ltd. is a technology-based enterprise founded by a postdoctoral researcher from the Chinese Academy of Sciences and a local government-owned enterprise, focusing on the development of immune cell and stem cell therapy technologies, as well as early diagnosis and intervention technologies for cancer [2] - The company has developed a tumor early diagnosis platform based on ctDNA methylation detection and a storage and preparation platform for immune cells and stem cells for precision treatment [2] - Jitao Medical is recognized as one of the first provincial-level new research and development institutions in Shandong Province and has received several accolades, including a national first prize in an innovation and entrepreneurship competition for its colorectal cancer early screening project [2] Investment and Infrastructure - The Weifang (Jitao) Regional Cell and Tissue Bank and Cell Preparation Center is located in a core area of Kuiwen District, with a total investment exceeding 20 million yuan, including a public life science popularization museum and a 1,200 square meter cell storage and preparation center [3] - The project incorporates cutting-edge international storage, preparation, and research and development equipment, adhering to national regulations and designed to meet international standards for clinical-grade and pharmaceutical-grade cell banks and preparation centers [3] - The company is focusing on the development of cell-based pharmaceuticals, with ongoing research on tumor-infiltrating lymphocyte (TIL) therapy for solid tumors, and is preparing to apply for national drug clinical trials [3]